140 related articles for article (PubMed ID: 34380851)
21. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
22. Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.
Chen AM; Felix C; Wang PC; Hsu S; Basehart V; Garst J; Beron P; Wong D; Rosove MH; Rao S; Melanson H; Kim E; Palmer D; Qi L; Kelly K; Steinberg ML; Kupelian PA; Daly ME
Lancet Oncol; 2017 Jun; 18(6):803-811. PubMed ID: 28434660
[TBL] [Abstract][Full Text] [Related]
23. Management of Fanconi Anemia patients with head and neck carcinoma: Diagnosis and treatment adaptation.
Beddok A; Krieger S; Castera L; Stoppa-Lyonnet D; Thariat J
Oral Oncol; 2020 Sep; 108():104816. PubMed ID: 32480311
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive molecular screening for oral precancer in Fanconi anemia patients.
Smetsers SE; Velleuer E; Dietrich R; Wu T; Brink A; Buijze M; Deeg DJ; Soulier J; Leemans CR; Braakhuis BJ; Brakenhoff RH
Cancer Prev Res (Phila); 2015 Nov; 8(11):1102-11. PubMed ID: 26276748
[TBL] [Abstract][Full Text] [Related]
25. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo inhibition of human Fanconi anemia head and neck squamous carcinoma by a phytonutrient combination.
Roomi MW; Kalinovsky T; Roomi NW; Niedzwiecki A; Rath M
Int J Oncol; 2015 May; 46(5):2261-6. PubMed ID: 25695860
[TBL] [Abstract][Full Text] [Related]
27. GS-nitroxide (JP4-039)-mediated radioprotection of human Fanconi anemia cell lines.
Bernard ME; Kim H; Berhane H; Epperly MW; Franicola D; Zhang X; Houghton F; Shields D; Wang H; Bakkenist CJ; Frantz MC; Forbeck EM; Goff JP; Wipf P; Greenberger JS
Radiat Res; 2011 Nov; 176(5):603-12. PubMed ID: 21939290
[TBL] [Abstract][Full Text] [Related]
28. Synchronous multifocal HPV-related neoplasm involving both the genital tract and the head-and-neck area: a case report of Fanconi anemia.
Han TJ; Lee CH; Yoo CW; Shin HJ; Park HJ; Cho KH; Park JY; Choi SW; Kim JY
Radiother Oncol; 2009 Jul; 92(1):138-41. PubMed ID: 19368986
[TBL] [Abstract][Full Text] [Related]
29. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma.
Bar-Ad V; Wang ZX; Leiby B; Tuluc M
J BUON; 2013; 18(4):982-8. PubMed ID: 24344027
[TBL] [Abstract][Full Text] [Related]
30. Fanconi anaemia: A syndrome with distinct subgroups.
Alter BP; Giri N; McReynolds LJ; Altintas B
Br J Haematol; 2022 May; 197(4):467-474. PubMed ID: 35191533
[TBL] [Abstract][Full Text] [Related]
31. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.
Masserot C; Peffault de Latour R; Rocha V; Leblanc T; Rigolet A; Pascal F; Janin A; Soulier J; Gluckman E; Socié G
Cancer; 2008 Dec; 113(12):3315-22. PubMed ID: 18831513
[TBL] [Abstract][Full Text] [Related]
32. Cancer stem cells are enriched in Fanconi anemia head and neck squamous cell carcinomas.
Wu J; Mu Q; Thiviyanathan V; Annapragada A; Vigneswaran N
Int J Oncol; 2014 Dec; 45(6):2365-72. PubMed ID: 25340704
[TBL] [Abstract][Full Text] [Related]
33. Factors affecting the outcome of related allogeneic hematopoietic cell transplantation in patients with Fanconi Anemia.
Ayas M; Siddiqui K; Al-Jefri A; El-Solh H; Al-Ahmari A; Khairy A; Markiz S; Shahin H; Al-Musa A; Al-Seraihy A
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1599-603. PubMed ID: 24960628
[TBL] [Abstract][Full Text] [Related]
34. Oral Tongue Cancer in a Patient with Fanconi Anemia: A Case Report and Literature Review.
Deng S; Ye W; Zhang S; Zhu G; Zhang P; Song Y; Duan F; Lang J; Lu S
Cancer Manag Res; 2021; 13():3145-3154. PubMed ID: 33883933
[TBL] [Abstract][Full Text] [Related]
35. Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer.
Stoepker C; Ameziane N; van der Lelij P; Kooi IE; Oostra AB; Rooimans MA; van Mil SE; Brink A; Dietrich R; Balk JA; Ylstra B; Joenje H; Feller SM; Brakenhoff RH
Cancer Res; 2015 Sep; 75(17):3543-53. PubMed ID: 26122845
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo inhibition of human Fanconi anemia-associated head and neck squamous cell carcinoma by a novel nutrient mixture.
Roomi MW; Kalinovsky T; Roomi NW; Niedzwiecki A; Rath M
Int J Oncol; 2012 Dec; 41(6):1996-2004. PubMed ID: 23007964
[TBL] [Abstract][Full Text] [Related]
37. Why otolaryngologists need to be aware of Fanconi anemia.
Lin J; Kutler DI
Otolaryngol Clin North Am; 2013 Aug; 46(4):567-77. PubMed ID: 23910470
[TBL] [Abstract][Full Text] [Related]
38. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
[TBL] [Abstract][Full Text] [Related]
39. Squamous cell carcinoma of the tongue in a child with Fanconi anemia: a case report and review of the literature.
Somers GR; Tabrizi SN; Tiedemann K; Chow CW; Garland SM; Venter DJ
Pediatr Pathol Lab Med; 1995; 15(4):597-607. PubMed ID: 8597846
[TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity.
Türke C; Horn S; Petto C; Labudde D; Lauer G; Wittenburg G
Int J Oncol; 2017 Jun; 50(6):2207-2220. PubMed ID: 28440438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
